Lisa L. von Moltke, MD, FCPP

A New Method for Initiating Treatment With the Long-acting Antipsychotic Aripiprazole Lauroxil

BACKGROUND: Significant delay can occur between the first dose of a long-acting injectable (LAI) antipsychotic and achievement of efficacious plasma concentrations, which is usually addre...

Lisa L. von Moltke , MD, FCPP;

Bhaskar Rege , PhD, BPharm;

Peter J. Weiden , MD, PhD;

Jonathan Meyer , MD;

Rakesh Jain , MD, MPH, RD;

Angela Wehr , PhD;

03/01/2019

Feature

Psychopharmacology in the Elderly Person with Cardiovascular Disease

09/05/2008

Richard A. Leigh-Pemberton , MD;

David J. Greenblatt , MD;

Lisa L. von Moltke , MD, FCPP;

Adequate treatment of conditions such as depression and psychosis in the elderly is an important component of appropriate medical care.

Adequate treatment of conditions...

09/05/2008

Annals of Long-Term Care

Safety and Efficacy of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Older Patients With Recurrent <italic>Clostridioides difficile</italic> Infection: Findings From an Integrated Analysis of Phase 3 Trials

1 Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic Main Campus, Cleveland, Ohio, United States; 2 Seres Therapeutics, Cambridge, Massachusetts, United States; ...

Bret Lashner ;

Lisa L. von Moltke , MD, FCPP;

Darrell S. Pardi ;

01/11/2024

A Combination of Olanzapine and Samidorphan Has No Clinically Relevant Effect on QT Prolongation Up to Supratherapeutic Doses

Background: ALKS 3831, a combination of olanzapine and samidorphan (OLZ/SAM) in development for schizophrenia, is intended to mitigate olanzapine-associated weight gain. This thorough QT ...

Lisa L. von Moltke , MD, FCPP;

Lei Sun , PhD;

Sergey Yagoda , PhD, MD;

Hongqu Xue , PhD;

Randy Brown , MS;

Narinder Nangia , PhD;

Bhaskar Rege , PhD, BPharm;

Borje Darpo , MD, PhD;

David McDonnell , MD;

11/22/2019